Company news

SureNano Science Ltd news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

SureNano Science Initiates FDA Stage GLP Toxicology and Pharmacology Studies for GLP GEP-44 and Enters Discussions to Acquire Ibogaine Formulation IP Portfolio

April 24, 2026

SureNano Science Ltd. Acquires GlucaPharm Inc., Advancing Second-Generation FDA Pathway GLP-1 Drug Development

February 23, 2026

SureNano Announces Stock Option Grant

December 12, 2025

SureNano Announces Closing of $1,250,000 Private Placement

December 10, 2025

SureNano Announces Non-Binding Letter of Intent to Negotiate Proposed Transaction of GlucaPharm Inc. for GLP-1 Drug Development

November 19, 2025

SureNano Announces Private Placement

November 5, 2025

SureNano Closes Financing

September 19, 2025

SureNano Announces Funding, Debt Settlement and AGSM Results

August 22, 2025

SureNano Science Announces DTC Eligibility

January 17, 2023

Decks